Quote:
Merck, Pfizer, Bristol, Abbvie, Gilead...where are the outsourced sales and marketing teams at these companies?
I don’t know what your issue is as an investor if you really are an investor. When all you do is sew doubt about CytoDyn growing into their own Big Pharmaceutical. You act like it’s impossible and yet claim to have done it before. I don’t know what to believe from you when it looks like your on the buy out push and nothing more. Saying over and over the sky is falling and it can’t happen in not just one post but a few posts you continue to crow the same message.
I would say that CytoDyn is in the right position to grow and has all bases covered temporarily with American Regent and Vyera for distribution of both indications that are most likely to be a EUA or BLA approved. You don’t know how long CytoDyn is constrained to those agreement any more than I do. But the point is they have the channel to distribute while they set themselves up to build their own sales and distribution team. It may not be an overnight hiring of the team necessary to take over all sales of Vyrologix right away but with big revenue and and money to burn hiring the best or stealing the best in the industry is what I would be thinking if I was looking for starting a Sales Department for CytoDyn.
You on the other hand just poo poo the whole idea over and over... what is your motive and why do you sew doubt for others? Do you think your helping with a future buy out idea? I personally am extremely happy that Nader Committed to building CytoDyn into its own “Big Pharmaceutical Company” that’s very exciting and a dream of a long investor. To not share revenue with other companies is exciting to me. It means a larger return on our value in stock. I will now stay much longer invested as they grow the company. You can take the quick bump in stock price on a EUA and go somewhere else if you actually have an investment in CYDY.
Read More: https://investorshangout.com/post/view?id=606...z6n1d0ptJd
Merck, Pfizer, Bristol, Abbvie, Gilead...where are the outsourced sales and marketing teams at these companies?
I don’t know what your issue is as an investor if you really are an investor. When all you do is sew doubt about CytoDyn growing into their own Big Pharmaceutical. You act like it’s impossible and yet claim to have done it before. I don’t know what to believe from you when it looks like your on the buy out push and nothing more. Saying over and over the sky is falling and it can’t happen in not just one post but a few posts you continue to crow the same message.
I would say that CytoDyn is in the right position to grow and has all bases covered temporarily with American Regent and Vyera for distribution of both indications that are most likely to be a EUA or BLA approved. You don’t know how long CytoDyn is constrained to those agreement any more than I do. But the point is they have the channel to distribute while they set themselves up to build their own sales and distribution team. It may not be an overnight hiring of the team necessary to take over all sales of Vyrologix right away but with big revenue and and money to burn hiring the best or stealing the best in the industry is what I would be thinking if I was looking for starting a Sales Department for CytoDyn.
You on the other hand just poo poo the whole idea over and over... what is your motive and why do you sew doubt for others? Do you think your helping with a future buy out idea? I personally am extremely happy that Nader Committed to building CytoDyn into its own “Big Pharmaceutical Company” that’s very exciting and a dream of a long investor. To not share revenue with other companies is exciting to me. It means a larger return on our value in stock. I will now stay much longer invested as they grow the company. You can take the quick bump in stock price on a EUA and go somewhere else if you actually have an investment in CYDY.
Read More: https://investorshangout.com/post/view?id=606...z6n1d0ptJd
10
